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Background: Guideline recommendations on therapy in urinary tract infections are based on antibiotic resistance
rates. Due to a lack of surveillance data, little is known about resistance rates in uncomplicated urinary tract
infection (UTI) in general practice in Germany. In a prospective observational study, urine cultures of all women
presenting with urinary tract infections in general practice were analysed. Resistance rates against antibiotics
recommended in German guidelines on UTI are presented.
Methods: In a prospective, multi-center observational study general practitioner included all female patients ≥
18 years with clinically suspected urinary tract infection. Only patients receiving an antibiotic therapy within the last
two weeks were excluded.
Results: 40 practices recruited 191 female patients (mean age 52 years; range 18–96) with urinary tract infections.
Main causative agent was Escherichia coli (79%) followed by Enterococcus faecalis (14%) and Klebsiella pneumoniae
(7.3%).
Susceptibiliy of E.coli as the main causative agent was highest against fosfomycin and nitrofurantoin, with low
resistance rates of 4,5%; 2,2%. In 17,5%, E.coli was resistant to trimethoprim and in 8,5% to ciprofloxacin.
Conclusions: Resistance rates of uropathogens from unselected patients in general practice differ from routinely
collected laboratory data. These results can have an impact on antibiotic prescribing and treatment
recommendations.
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Antibiotic resistance is an emerging and serious public
health problem resulting in increased morbidity and
mortality. In urinary tract infections (UTI), resistance
rates against commonly prescribed antimicrobial agents
are constantly rising. Nowadays, in many countries more
than 20% of responsible uropathogens are resistant to
trimethoprim /sulfamethoxazole (tmp-smx) and to
cephalosporins. This increasing resistance is also being
observed for fluoroquinolones with resistance rates,
risen up to 10% [1,2]. As medicine faces a bleak outlook
on availability of effective antibiotic treatment, new
therapeutic strategies for urinary tract infections are
necessary.* Correspondence: schmiemann@uni-bremen.de
1Department for Health Services Research, Institute for Public Health and
Nursing Science, Universität Bremen, Bremen, Germany
Full list of author information is available at the end of the article
© 2012 Schmiemann et al.; licensee BioMed C
Creative Commons Attribution License (http:/
distribution, and reproduction in any mediumIn 2011 an action plan has been launched by the Euro-
pean Commission [3] to tackle these problems. Aims
and strategies include the promotion of a restrictive and
appropriate use of antibiotics as well as the promotion
of national surveillance programs. To optimize antibiotic
treatment of uncomplicated UTI, the latter is urgently
required for several reasons:
 Although the majority of antibiotic prescribing for
uncomplicated UTI takes place in primary care,
information on antibiotic resistance is mainly based
on data from hospitals or laboratories, i.e. - highly
selected patients. Thus, results cannot be
generalized to UTI patients in general practice who
are likely to present with lower resistance rates.
 In general practice, urine sample of patients with
UTI are not routinely tested for resistance patterns.
According to German guidelines on UTI [4,5],entral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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treatment failure or suspected complications.
 Resistance patterns of causative uropathogens are
known to vary considerably between regions and
countries [1].
In Germany, as in many other countries, there is no
sentinel network which routinely assesses resistance
rates of urinary tract infections in general practice [6].
In face of all these facts, a prospective observational
study to target antibiotic therapy in uncomplicated UTI
tackles the following questions:
Which uropathogens cause uncomplicated UTI in
general practice?
To what extent are these uropathogens susceptible to
antibiotics recommended in German guidelines?
Method
The study idea emerged in a web based discussion
forum of German general practitioners hosted by the
German College of General Practitioners and Family
Physicians. A prospective multi-center observational
study design was set up. 579 physicians participating in
the web based discussion forum and 193 teaching prac-
tices of the Institute of General Practice of Hannover
Medical School were invited for participation via e-mail.
During a six week period in autumn 2011, participat-
ing practices were asked to include all female patients ≥
18 years in whom urinary tract infection was suspected.
The only exclusion criterion was antibiotic therapy
within the last two weeks.
After written consent was obtained, patients were
asked to provide a clean catch midstream urine sample.
The sample was sent to the local laboratory. All labora-
tories were asked to perform resistance testing at least
for trimethoprim, ciprofloxacin, nitrofurantoin and fos-
fomycin, even if these antibiotics were not being tested
routinely.
For classification of UTI and prevailing risk factors,
patient data on age, pregnancy status, indwelling urine
catheter, risk factors for a complicated infection (i.e. hos-
pital stay within the last 2 weeks, immunosuppression,
or neurological disease affecting micturition), and previ-
ous UTI were documented by the general practitioners
(GP) from patients’ records.
Patient data and laboratory results were entered into a
web based survey instrument (lime-surveyW) in anonym-
ous form. Access to the database was restricted by a per-
sonal access token and performed by medical staff. The
patients themselves had no access to the database.
For financial reasons – the study was conducted with-
out external funding - a central laboratory was not feas-
ible. Laboratories conducting urine analyses have to be
certified and have to use standardized methods, eitherDIN, EuCast or CLSI. All urine cultures/susceptibility
tests were performed in the laboratories the practices
were attached to. Susceptibility of the causative bacteria
was categorized as susceptible (S), intermediate (I) or
resistant (R).
Quality control: a randomized sample of 5% of all
patients (n = 14) was drawn by the investigators. A study
assistant compared patient data and results of suscepti-
bility testing entered in the web based survey with the
original data held on file in the practice. The comparison
was based on a re- identification code known to the
practice only. Neither causative agents nor susceptibility
results had to be corrected due to the quality control.
Descriptive data analysis (absolute and relative fre-
quencies) was performed descriptively using Microsoft
Excel©.
Microbiological methods: Native midstream urine was
sent to the laboratories. Laboratories were asked to per-
form a routine urine culture and identification of patho-
gens as well as susceptibility testing including
trimethoprim, fosfomycine-trometamol, nitrofurantoin
and ciprofloxacin. These agents were chosen as they are
recommended by national guidelines [5]. Positive urine
culture was defined as bacterial count ≥ 103 cfu/ml.
Approval of the ethics committee of Hannover Med-
ical School was obtained (N0. 1138 2011).
Results
Participating practices/patient recruitment
67 practices expressed their willingness to participate,
40 practices included patients (Ø 4.8 patients/practice).
Patient recruitment was not possible for some practices
(n = 4) as their laboratory would not provide the recom-
mended antibiotic tests against trimethoprim or fosfo-
mycin. [Most of the participating practices were from
Lower Saxony (28/40).]
Within the six week study period, most practices
(n = 25) included 1–5 patients; 13 practices included
6–10 patients and two practices included more than
11 patients.
Patient characteristics
191 women with positive urine culture were included.
The mean age was 51.6 years (SD 21.7; Range 18–96).
The most prevalent risk factors for UTI were diabetes
mellitus (9.6%; 18/191) and recurrent UTI 18.3%
(n = 35). (see Table 1 for details).
Urine culture and uropathogens
In 36.1% of urine cultures, more than one species could
be identified; relevant uropathogens from all cultures
were included.
Escherichia coli was found to be the causative patho-
gen in 72.8% (139/191). Other typical uropathogens
Table 1 Patient characteristics
% Patients (n = 191)




Indwelling urinary catheter 0%
Other risk factor 3.1%
Characteristics of 191 female patients with urinary tract infections.
SD = standard deviation, Recurrent UTI = Previous Urinary tract infection in
the last 6 month; Other risk factors = hospital stay within the last 2 weeks,
immunosuppression or neurological disease affecting micturition.
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ella pneumoniae (n = 14; 7.3%), Proteus mirabilis (n = 11)
(see Table 2).
Susceptibility testing
Susceptibiliy of E.coli as the main causative agent was
highest against fosfomycin and nitrofurantoin, with low
resistance rates of 4,5% resp. 2,2%. In 17,5%, E.coli was
resistant to TMP and in 8,5% to ciprofloxacin. In con-
trast to E.coli, other typical uropathogens showed higher
resistance rates for TMP, fosfomycin and nitrofurantoin
(50%, 21.7%, 23.8%).
Ciprofloxacin is equally effective against E. coli and
other typical uropathogens (8.7%; 8.1%). Further results
on susceptibility are presented in detail in Table 2.
In a few cases a urine culture was not tested for all
antibiotics requested. This refers mainly to trimethoprim
(130/139 samples were tested) and reflects the lack of a
standard in antibiotic testing among laboratories (see
Table 2).Table 2 Bacteria detected and susceptibility profile
Isolates n (%) Trimethoprim Fosfom
S n (%) I n (%) R n (%) S n (%) I n (%
All 191 (100)
E. coli 139 (72.7) 105 (80.8) 2 (1.7) 23 (17.5) 126 (95.5) 0 (0
Other typical
uropathogens
71 (37.2) 28 (50) 0 28 (50) 46 (76,8) 1 (1.
Enterococcus
faecalis
26 (13.6) 6 0 14 15 1
Proteus mirabilis 11 (5.7) 1 0 8 8 0
Staph.
saprophyticus
4 (2.1) 4 0 0 3 0
Staph. others 5 (2.6) 1 0 2 3 0
Strept.
agalacticae
8 (4.2) 2 0 3 7 0
Kleb
pneumoniae
14 (7.3) 12 0 1 10 0
Staph. aureus 3 (1.6) 2 0 0 0 0
In the first column typical uropathogens and the number of isolates are documente
other typical uropathogens are presented. Due to the low numbers no percent rateRecurrent UTI
35 patients had experienced a previous urinary tract infec-
tion in the last six months. Besides E.coli (29/35), causative
pathogens in recurrent infections were Staphylococcus
aureus, Enterococcus faecalis, Proteus mirabilis, Staphylo-
coccus saprophyticus and Klebsiella pneumoniae.
In recurrent UTI, E.coli showed higher resistance rates
against trimethoprim (25%) and ciprofloxacin (17%)
while resistance rates for nitrofurantoin (3.4%) and fos-
fomycin (0%) were very low.
Discussion
In this prospective observational study, causative agents
and susceptibility results in uncomplicated UTI in gen-
eral practice were collected with a pragmatic approach.
Though participating practices constitute a (self-
selected) convenience sample which cannot be consid-
ered representative, practices were located widely across
(predominately north western) Germany. Pragmatic in-
clusion criteria were given for patients to facilitate re-
cruitment, based on the GPs clinical judgment, which is
usually based on patient history and symptoms. While
participating practices are likely to be more interested in
research (and possibly in antibiotic resistance) than non-
participating or non-recruiting practices, it seems un-
likely that their patients are different [7].
Thus, general practice based information on resistance
patterns of typical uropathogens in general practice in
Germany can be provided for the first time. Comparing
our results with reports of routinely collected data from
a more specialized level of care [8,9] revealed relevant
differences (Table 3). Antibiotic resistance against tri-
methoprim, a drug recommended by many guidelinesycin Nitrofurantoin Ciprofloxacin
) R n (%) S n (%) I n (%) R n (%) S n (%) I n (%) R n (%)
) 6 (4.5) 130 (94.2) 5 (3.6) 3 (2.2) 126 (91.3) 0 (0) 12 (8.7)
7) 13 (21.7) 43 (68.2) 5 (7.9) 15 (23.8) 48 (77.4) 9 (14.5) 5 (8.1)
6 21 0 2 16 5 2
0 0 0 10 9 0 0
1 4 0 0 4 0 0
0 1 2 0 2 1 0
0 7 0 0 2 3 2
4 9 2 3 13 0 1
2 1 1 0 2 0 0
d. In the upper two rows results of susceptibility testing against E. coli and all
s are given in the remaining rows.










TMP 17.5 29.2 28.7 25.9
Nitrofurantoin 2.2 n.a 1.2 4.5
Fosfomycin 4.5 n.a n.a 0.8
Ciprofloxacin 8.7 18.2 13.9 4.5
With exception of our study all others used TMP-SMX. N.A = No information
on susceptibility rates given.
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general practice patients compared with laboratory sur-
veillance data. Ciprofloxacin, an antibiotic recommended
for complicated infections, also shows higher susceptibil-
ity in primary care. Fosfomycin and nitrofurantoin still
have remarkably low resistance rates, probably due to
quite low prescription rates in Germany. Our results
confirm that urine cultures submitted to laboratories do
not represent the susceptibility patterns in unselected
patients [12,13]since in these patients urine cultures are
only requested if the patient fails to respond to treat-
ment, has recurrent episodes or other complicating fac-
tors. Thus, in the primary care setting, urine cultures for
suspected UTI remain exceptional and represent compli-
cated rather than typical uncomplicated patients. There-
fore, data from laboratory results [8,9] or studies
including data from patients in specialist care (urology,
gynecology) [14] differ from our results, they do not rep-
resent the antimicrobial resistance situation in general
practice in Germany.
The strength of our study is its pragmatic approach in
the general practice setting, resulting in a high number
of (uncomplicated) patients recruited in a very short
period of time. A direct comparison with two epidemio-
logical German studies [14,15] is limited as these studies
included only women up to 65 years under specialists
care. This may well explain the low number of patients
with diabetes mellitus (4.8%) found by Wagenlehner
compared with 9.6% in our study including elderly
women. The lack of a central laboratory resulting in dif-
ferent sets of antibiotics used for routine susceptibility
testing, or available for testing at all proved a limit in
obtaining comparable susceptibility data for all patients
within our study. However, pooling results from different
certified laboratories is routinely done when reporting of
antimicrobial resistance rates [8]. Therefore the fact of
using pooled data from different local laboratories in-
stead of a central one is unlikely to bias our results. In
any case, it reflects usual practice and usual community
based care in Germany.
National or regional standards for the selection of
antibiotics to be included in susceptibility analysis are
missing in Germany, as well as legal pressure to includeantibiotics recommended in guidelines. In many micro-
biological laboratories, routinely conducted tests often
do not include all antimicrobial agents recommended by
current guidelines, for example, fosfomycin-trometamol
or nitrofurantoin are often missing. This constitutes a
very relevant barrier against guideline implementation
and appropriate use of antibiotics.
Resistance rates of common uropathogens have an im-
portant impact on guideline recommendations regarding
the choice of antibiotics. Although there is no linear cor-
relation between resistance level and strength of a
recommendation, rising resistance rates compromise ac-
ceptance of a recommendation, and confirmed lower re-
sistance profiles imply the need to review a guideline
recommendation. Based on expert consensus, usually a
resistance level of >20% is used as a cut-off in guidelines
on urinary tract infections [16,17].
With a resistance rate of 17.5% for the main causative
agent E. coli, our results confirm the recommendation of
TMP as a first choice antibiotic substance in the Ger-
man primary care setting.
An urgent task for the future is to build up a sentinel
network. Only by collecting resistance data permanently,
a tailored and specific antibiotic therapy of UTI is per-
mitted. This also implies implementation of guideline-
adjusted resistance testing in medical laboratories.Conclusions
Resistance rates of uropathogens from unselected
patients in general practice differ from routinely col-
lected data from laboratories. These results have a major
effect on antibiotic prescribing and treatment recom-
mendations. Sentinel networks for a representative UTI
resistance data are urgently needed to monitor UTI
resistances in general practice.
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